These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 26578231)

  • 1. Impact of Genetic Counseling and Testing on Altruistic Motivations to Test for BRCA1/2: a Longitudinal Study.
    Garg R; Vogelgesang J; Kelly K
    J Genet Couns; 2016 Jun; 25(3):572-82. PubMed ID: 26578231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions.
    Geller G; Doksum T; Bernhardt BA; Metz SA
    Cancer Epidemiol Biomarkers Prev; 1999 Apr; 8(4 Pt 2):377-83. PubMed ID: 10207643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer Risk Information Sharing: The Experience of Individuals Receiving Genetic Counseling for BRCA1/2 Mutations.
    Chopra I; Kelly KM
    J Health Commun; 2017 Feb; 22(2):143-152. PubMed ID: 28112991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "I Don't Want to Be an Ostrich": Managing Mothers' Uncertainty during BRCA1/2 Genetic Counseling.
    Fisher CL; Roccotagliata T; Rising CJ; Kissane DW; Glogowski EA; Bylund CL
    J Genet Couns; 2017 Jun; 26(3):455-468. PubMed ID: 27473644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer genetics knowledge and beliefs and receipt of results in Ashkenazi Jewish individuals receiving counseling for BRCA1/2 mutations.
    Kelly K; Leventhal H; Marvin M; Toppmeyer D; Baran J; Schwalb M
    Cancer Control; 2004; 11(4):236-44. PubMed ID: 15284715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect on perceived control and psychological distress of genetic knowledge in women with breast cancer receiving a BRCA1/2 test result.
    Brédart A; Kop JL; De Pauw A; Caron O; Fajac A; Noguès C; Stoppa-Lyonnet D; Dolbeault S
    Breast; 2017 Feb; 31():121-127. PubMed ID: 27837705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subjective and objective risk of ovarian cancer in Ashkenazi Jewish women testing for BRCA1/2 mutations.
    Kelly KM; Senter L; Leventhal H; Ozakinci G; Porter K
    Patient Educ Couns; 2008 Jan; 70(1):135-42. PubMed ID: 17988821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expanding access to BRCA1/2 genetic counseling with telephone delivery: a cluster randomized trial.
    Kinney AY; Butler KM; Schwartz MD; Mandelblatt JS; Boucher KM; Pappas LM; Gammon A; Kohlmann W; Edwards SL; Stroup AM; Buys SS; Flores KG; Campo RA
    J Natl Cancer Inst; 2014 Dec; 106(12):. PubMed ID: 25376862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "For all my family's sake, I should go and find out": an Australian report on genetic counseling and testing uptake in individuals at high risk of breast and/or ovarian cancer.
    Wakefield CE; Ratnayake P; Meiser B; Suthers G; Price MA; Duffy J; Tucker K;
    Genet Test Mol Biomarkers; 2011 Jun; 15(6):379-85. PubMed ID: 21254855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The decision to test in women receiving genetic counseling for BRCA1 and BRCA2 mutations.
    Kelly K; Leventhal H; Andrykowski M; Toppmeyer D; Much J; Dermody J; Marvin M; Baran J; Schwalb M
    J Genet Couns; 2004 Jun; 13(3):237-57. PubMed ID: 15604634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subjective and objective risk of breast cancer in Ashkenazi Jewish individuals at risk for BRCA1/2 mutations.
    Kelly K; Leventhal H; Marvin M; Toppmeyer D; Much J; Dermody J; Baran J; Schwalb M
    Genet Test; 2004; 8(2):139-47. PubMed ID: 15345111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bilateral prophylactic oophorectomy and ovarian cancer screening following BRCA1/BRCA2 mutation testing.
    Schwartz MD; Kaufman E; Peshkin BN; Isaacs C; Hughes C; DeMarco T; Finch C; Lerman C
    J Clin Oncol; 2003 Nov; 21(21):4034-41. PubMed ID: 14581427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic counseling for BRCA1/BRCA2 testing.
    Schneider KA
    Genet Test; 1997; 1(2):91-8. PubMed ID: 10464632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opening the psychological black box in genetic counseling. The psychological impact of DNA testing is predicted by the counselees' perception, the medical impact by the pathogenic or uninformative BRCA1/2-result.
    Vos J; Gómez-García E; Oosterwijk JC; Menko FH; Stoel RD; van Asperen CJ; Jansen AM; Stiggelbout AM; Tibben A
    Psychooncology; 2012 Jan; 21(1):29-42. PubMed ID: 21072753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BRCA1/2 genetic testing in the community setting.
    Chen WY; Garber JE; Higham S; Schneider KA; Davis KB; Deffenbaugh AM; Frank TS; Gelman RS; Li FP
    J Clin Oncol; 2002 Nov; 20(22):4485-92. PubMed ID: 12431973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Issues of concern in risk assessment, genetic counseling, and genetic testing of younger breast cancer patients in Japan.
    Bando H
    Breast Cancer; 2014 Nov; 21(6):656-63. PubMed ID: 23754181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding of BRCA1/2 genetic tests results: the importance of objective and subjective numeracy.
    Hanoch Y; Miron-Shatz T; Rolison JJ; Ozanne E
    Psychooncology; 2014 Oct; 23(10):1142-8. PubMed ID: 24733657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample.
    Schwartz MD; Peshkin BN; Hughes C; Main D; Isaacs C; Lerman C
    J Clin Oncol; 2002 Jan; 20(2):514-20. PubMed ID: 11786581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.